Chugai Pharmaceutical Co., Ltd.

Chugai Pharmaceutical Co., Ltd.verified

CHGCF

Price:

$55.41

Market Cap:

$13.55T

Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, FoundationOne, Polivy, Rozlytrek, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, and Gazyva; osteoporosis, including Actemra, Edirol, and Bonviva; Mircera, an erythropoiesis agent; Oxarol, an agent for secondary hyperparathyroidism; and other diseases comprise Hemlibra, CellCept, Tamiflu, Evrysdi, Ronapreve, Vabysmo, and Enspryng. It has various development product candidates in the areas of oncology, immunology, neurosci...[Read more]

Industry

Drug Manufacturers - General

IPO Date

2012-08-03

Stock Exchange

OTC

Ticker

CHGCF

The ROE as of December 2025 (TTM) for Chugai Pharmaceutical Co., Ltd. (CHGCF) is 20.83%

According to Chugai Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 20.83%. This represents a change of 298.85% compared to the average of 5.22% of the last 4 quarters.

Chugai Pharmaceutical Co., Ltd. (CHGCF) Historical ROE (quarterly & annually)

How has CHGCF ROE performed in the past?

The mean historical ROE of Chugai Pharmaceutical Co., Ltd. over the last ten years is 17.34%. The current 20.83% ROE has changed 20.15% with respect to the historical average. Over the past ten years (40 quarters), CHGCF's ROE was at its highest in in the March 2022 quarter at 10.62%. The ROE was at its lowest in in the December 2016 quarter at 1.63%.

Quarterly (TTM)
Annual

Average

17.34%

Median

19.24%

Minimum

8.30%

Maximum

26.29%

Chugai Pharmaceutical Co., Ltd. (CHGCF) ROE by Quarter and Year

Discovering the peaks and valleys of Chugai Pharmaceutical Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 50.78%

Maximum Annual ROE = 26.29%

Minimum Annual Increase = -23.83%

Minimum Annual ROE = 8.30%

Quarterly (TTM)
Annual
YearROEChange
202420.37%1.73%
202320.02%-23.83%
202226.29%3.07%
202125.50%16.40%
202021.91%18.76%
201918.45%50.78%
201812.24%16.44%
201710.51%26.58%
20168.30%-14.99%
20159.77%14.20%

Chugai Pharmaceutical Co., Ltd. (CHGCF) Average ROE

How has CHGCF ROE performed in the past?

The current ROE of Chugai Pharmaceutical Co., Ltd. (CHGCF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

22.23%

5-year avg

22.82%

10-year avg

17.34%

Chugai Pharmaceutical Co., Ltd. (CHGCF) ROE vs. Peers

How is CHGCF’s ROE compared to its peers?

Chugai Pharmaceutical Co., Ltd.’s ROE is less than GSK plc (37.40%), less than Daiichi Sankyo Company, Limited (18.35%), less than Daiichi Sankyo Company, Limited (18.35%), less than Siemens Healthineers AG (11.56%), less than Merck KGaA (9.85%), less than Merck KGaA (9.85%), less than Sartorius AG (4.95%), less than CSL Limited (17.37%), less than HOYA Corporation (21.05%), less than Ipsen S.A. (10.65%),

Build a custom stock screener for Chugai Pharmaceutical Co., Ltd. (CHGCF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chugai Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Chugai Pharmaceutical Co., Ltd. (CHGCF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Chugai Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Chugai Pharmaceutical Co., Ltd.'s ROE?

How is the ROE calculated for Chugai Pharmaceutical Co., Ltd. (CHGCF)?

What is the highest ROE for Chugai Pharmaceutical Co., Ltd. (CHGCF)?

What is the 3-year average ROE for Chugai Pharmaceutical Co., Ltd. (CHGCF)?

What is the 5-year average ROE for Chugai Pharmaceutical Co., Ltd. (CHGCF)?

How does the current ROE for Chugai Pharmaceutical Co., Ltd. (CHGCF) compare to its historical average?